Exposure
Map route, dose, duration, frequency, contact surface and affected population.
Deployment evaluation · 15
Human, biological and environmental safety
Assess contact, entanglement, pressure, heat, toxicity, immune response, contamination, degradation products and ecological persistence for the intended context.
Evidence statusResearch-frontier evidence framework · stage, material, control and retrieval validation requiredLast reviewed: 16 August 2026
15
FUURAA thesis
Small and soft systems introduce different hazards; they do not remove hazard analysis.
Engineering map
Turn the title into engineering objects that can be observed, measured and reviewed.
Each layer states the boundary to establish and the evidence needed for the next decision.
Response
Measure mechanical, thermal, chemical, biological and ecological outcomes.
Control
Define containment, monitoring, stop, cleanup, medical response and disposal.
Verification questions
Write the questions first, then decide whether a demo, test, pilot or operating record can answer them.
Each question needs an object, conditions, denominator, threshold and accountable decision owner.
- 01
Which materials and degradation products are present?
- 02
What exposure differs from the comparator?
- 03
How are fragments, leaks or uncontrolled agents detected?
- 04
Which long-term or repeated-exposure evidence is missing?
Evidence to preserve
Enable the next reader to reconstruct conditions, results, failures and the decision.
A conclusion alone loses reviewability; raw records, configuration and exclusions matter too.
- 01
Evidence package 1
Material composition and exposure assessment
- 02
Evidence package 2
Context-specific mechanical and biological testing
- 03
Evidence package 3
Containment, cleanup and residual-impact record
Scope boundary
State what this evidence still cannot be generalised to.
- 01
Compliance, biodegradability or nanoscale dimensions alone do not establish safety; evaluation remains product-, dose- and context-specific.
- 02
This is an engineering reading and decision framework; it does not replace application-specific risk assessment, conformity work, procurement acceptance or professional advice.
Sources and evidence status
Read standards scope, measurement evidence and application conclusions separately.
Source dates and review status remain visible; external sources open in a new tab.
01
U.S. Food and Drug Administration · Final guidance 2014-06 · verified 2026-08-16
↗02Considering whether an FDA-regulated product involves nanotechnology
Explains that dimension-dependent properties may require particular, product-specific attention to safety, effectiveness, quality and regulatory status.
ETH Zurich · Published 2025-11-13 · verified 2026-08-16
↗03Magnetically guided microrobots for targeted drug delivery
Integrates a soluble capsule, magnetic navigation, X-ray visibility, catheter release and drug delivery, with testing in vascular models and large animals.
NIST · Published 2024-06 · verified 2026-08-16
↗Research Opportunities for Advancing Measurement Science for Manufacturing Robotics
Identifies soft-robotics measurement needs across actuation, sensor integration, control, power, fabrication and materials, and calls for comparison with rigid and other alternatives.